|
Volumn 156, Issue 12, 2012, Pages 892-893
|
Lipitor goes generic: Business as usual or more big business?
a a a a
a
NONE
(United States)
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ATORVASTATIN;
CLOPIDOGREL;
ESCITALOPRAM;
GENERIC DRUG;
MEVINOLIN;
PIOGLITAZONE;
PRAVASTATIN;
SIMVASTATIN;
ARTICLE;
COUNSELING;
DRUG COST;
DRUG EFFICACY;
DRUG INDUSTRY;
DRUG SAFETY;
HEALTH BEHAVIOR;
HEALTH CARE COST;
HEALTH PROGRAM;
HOSPITAL BILLING;
HUMAN;
MEDICAID;
MEDICAL PROCEDURES;
MEDICARE;
PATIENT CARE;
PHARMACIST;
PHARMACY;
PHYSICIAN;
PRESCRIPTION;
PRIORITY JOURNAL;
PRIVATE HEALTH INSURANCE;
SYSTEMATIC REVIEW (TOPIC);
|
EID: 84862741653
PISSN: 00034819
EISSN: 15393704
Source Type: Journal
DOI: 10.7326/0003-4819-156-12-201206190-00420 Document Type: Article |
Times cited : (4)
|
References (12)
|